首页> 外国专利> APPLICATION OF MELOXICAM FOR TREATMENT OF RESPIRATORY DISEASES IN PIGS

APPLICATION OF MELOXICAM FOR TREATMENT OF RESPIRATORY DISEASES IN PIGS

机译:美洛昔康在猪呼吸道疾病中的应用

摘要

1. The use of meloxicam or its pharmaceutically acceptable salt to obtain a pharmaceutical composition for the treatment or prevention of respiratory diseases in pigs. The use according to claim 1, characterized in that the pharmaceutical composition is presented in a form suitable for systemic or oral administration. The use according to claim 1 or 2, characterized in that the pharmaceutical composition is administered in a daily dosage in the range from 0.01 to 5.0 mg / kg. The use according to claim 3, characterized in that the pharmaceutical composition is presented in a form suitable for injection, or in the form of soluble granules for administration with drinking water or as an additive to food. The use according to claim 3, characterized in that meloxicam is administered in combination with an antibiotic. The use according to claim 5, characterized in that meloxicam is administered in combination with an antibiotic selected from the group consisting of β-lactams, quinolones, tetracyclines, sulfanilamides, phenols and macrolides. The use according to claim 6, characterized in that meloxicam is administered in combination with oxytetracycline or chlortetracycline. The use according to claim 4, characterized in that the drug is used to prevent or treat complex respiratory disease of pigs at the stage of raising or fattening pigs. The use according to claim 4, characterized in that the drug is used to prevent or treat respiratory diseases of pigs caused by mycoplasmas, bacteria or viruses. The use according to claim 4, characterized in that the drug is used to prevent or treat respiratory diseases of pigs caused by Mycoplasma hyopneumoniae, Mycoplasma hyorhinis, Actin
机译:1.美洛昔康或其药学上可接受的盐在获得用于治疗或预防猪呼吸道疾病的药物组合物中的用途。 2.根据权利要求1的用途,其特征在于所述药物组合物以适合于全身或口服给药的形式存在。 3.根据权利要求1或2所述的用途,其特征在于,所述药物组合物以0.01至5.0mg / kg的日剂量给药。 4.根据权利要求3所述的用途,其特征在于,所述药物组合物以适于注射的形式或与饮用水一起施用或作为食品添加剂的可溶性颗粒形式存在。 4.根据权利要求3的用途,其特征在于美洛昔康与抗生素组合给药。 6.根据权利要求5所述的用途,其特征在于,美洛昔康与选自β-内酰胺,喹诺酮,四环素,磺胺类,酚类和大环内酯类的抗生素联合施用。 7.根据权利要求6的用途,其特征在于美洛昔康与土霉素或金霉素联合施用。 5.根据权利要求4所述的用途,其特征在于,所述药物用于在猪的饲养或肥育阶段预防或治疗猪的复杂呼吸道疾病。 5.根据权利要求4所述的用途,其特征在于,所述药物用于预防或治疗由支原体,细菌或病毒引起的猪的呼吸道疾病。 5.根据权利要求4所述的用途,其特征在于,所述药物用于预防或治疗由猪肺炎支原体,猪支原体,肌动蛋白引起的呼吸道疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号